ID: 2036 Next-generation sequencing to evaluate frequency of BCR-ABL1 kinase domain Imatinib-resistance mutations. (2017). Biomedical Research and Therapy, 4(S), S67. https://doi.org/10.15419/bmrat.v4iS.275